Embed

Academic

Authors

Jean Geneve

Jean Geneve (Jean Genève),Institut National de la Santé et de la Recherche Médicale,Oncology,Biotechnology,Virology

Edit

Jean Geneve (Jean Genève)

Institut National de la Santé et de la Recherche Médicale

Publications: 26 | Citations: 171

Fields: Oncology, Biotechnology, Virology

Collaborated with 147 co-authors from 2005 to 2011 | Cited by 837 authors

Cumulative Annual

Sort by:

Publications (26)

BibTeX | RIS | RefWorks Download

Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: A French Geriatric Oncology Group (GERICO) phase II multicentre trial (Citations: 3)

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=49500646&selfId1=8472820&selfId2=0&maxNumber=12&query=

Journal: Critical Reviews in Oncology Hematology - CRIT REV ONCOL HEMATOL , vol. 80, no. 1, pp. 160-170, 2011

Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer (Citations: 2)

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=29117534&selfId1=8472820&selfId2=0&maxNumber=12&query=

Journal: Breast Cancer Research and Treatment - BREAST CANCER RES TREAT , vol. 127, no. 2, pp. 363-373, 2011

Effect of XELOX on functional ability among elderly patients with metastatic colorectal cancer: Results from the FNCLCC/GERICO 02 phase II study (Citations: 1)

, , , , , , , , ,

Journal: Journal of Geriatric Oncology , vol. 2, no. 2, pp. 105-111, 2011

Impact of an all-oral capecitabine and vinorelbine combination regimen on functional status of elderly patients with advanced solid tumours: A multicentre pilot study of the French geriatric oncology group (GERICO) (Citations: 4)

, , , , , , , , , ,

Journal: Critical Reviews in Oncology Hematology - CRIT REV ONCOL HEMATOL , vol. 76, no. 1, pp. 71-78, 2010

Participants’ uptake of clinical trial results: a randomised experiment (Citations: 2)

, , , , , , , , , , ,

Journal: British Journal of Cancer - BRIT J CANCER , vol. 102, no. 7, pp. 1081-1084, 2010

Sort by:

Citations (171 times by 163 publications)

Transparency in the presentation of trial results may not increase patients’ trust in medical researchers

, , , , , ,

Journal: Clinical Trials - CLIN TRIALS , vol. 9, no. 1, pp. 90-93, 2012

BCL2A1: the underdog in the BCL2 family

Journal: Cell Death and Differentiation - CELL DEATH DIFFERENTIATION , vol. 19, no. 1, pp. 67-74, 2012

Genomic predictors of response to doxorubicin versus docetaxel in primary breast cancer (Citations: 3)

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=48797061&selfId1=8472820&selfId2=0&maxNumber=12&query=

Journal: Breast Cancer Research and Treatment - BREAST CANCER RES TREAT , vol. 128, no. 1, pp. 127-136, 2011

Relative dose intensity of chemotherapy and its impact on outcomes in patients with early breast cancer or aggressive lymphoma (Citations: 2)

Journal: Critical Reviews in Oncology Hematology - CRIT REV ONCOL HEMATOL , vol. 77, no. 3, pp. 221-240, 2011

Risk factors for chemotherapy-induced neutropenia occurrence in breast cancer patients: data from the INC-EU Prospective Observational European Neutropenia Study (Citations: 1)

, , , , , , ,

Journal: Supportive Care in Cancer - SUPPORT CARE CANCER , vol. 19, no. 4, pp. 483-490, 2011

Comments

Co-authors (147)

Journals (14)

Keywords (68)

Jean Geneve (Jean Genève),Institut National de la Santé et de la Recherche Médicale,Oncology,Biotechnology,Virology

Publications (26)

BibTeX | RIS | RefWorks Download

Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: A French Geriatric Oncology Group (GERICO) phase II multicentre trial (Citations: 3)

Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer (Citations: 2)

Effect of XELOX on functional ability among elderly patients with metastatic colorectal cancer: Results from the FNCLCC/GERICO 02 phase II study (Citations: 1)

Impact of an all-oral capecitabine and vinorelbine combination regimen on functional status of elderly patients with advanced solid tumours: A multicentre pilot study of the French geriatric oncology group (GERICO) (Citations: 4)

Participants’ uptake of clinical trial results: a randomised experiment (Citations: 2)

Citations (171 times by 163 publications)

Transparency in the presentation of trial results may not increase patients’ trust in medical researchers

BCL2A1: the underdog in the BCL2 family

Genomic predictors of response to doxorubicin versus docetaxel in primary breast cancer (Citations: 3)

Relative dose intensity of chemotherapy and its impact on outcomes in patients with early breast cancer or aggressive lymphoma (Citations: 2)

Risk factors for chemotherapy-induced neutropenia occurrence in breast cancer patients: data from the INC-EU Prospective Observational European Neutropenia Study (Citations: 1)


	View FAQ about top research areas and Fields of study

Co-authors (147)

Journals (14)

Keywords (68)

Jean Geneve (Jean Genève),Institut National de la Santé et de la Recherche Médicale,Oncology,Biotechnology,Virology

Publications (26) BibTeX | RIS | RefWorks Download

Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: A French Geriatric Oncology Group (GERICO) phase II multicentre trial (Citations: 3)

Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer (Citations: 2)

Effect of XELOX on functional ability among elderly patients with metastatic colorectal cancer: Results from the FNCLCC/GERICO 02 phase II study (Citations: 1)

Impact of an all-oral capecitabine and vinorelbine combination regimen on functional status of elderly patients with advanced solid tumours: A multicentre pilot study of the French geriatric oncology group (GERICO) (Citations: 4)

Participants’ uptake of clinical trial results: a randomised experiment (Citations: 2)

Citations (171 times by 163 publications)

Transparency in the presentation of trial results may not increase patients’ trust in medical researchers

BCL2A1: the underdog in the BCL2 family

Genomic predictors of response to doxorubicin versus docetaxel in primary breast cancer (Citations: 3)

Relative dose intensity of chemotherapy and its impact on outcomes in patients with early breast cancer or aggressive lymphoma (Citations: 2)

Risk factors for chemotherapy-induced neutropenia occurrence in breast cancer patients: data from the INC-EU Prospective Observational European Neutropenia Study (Citations: 1)

Publications (26)

BibTeX | RIS | RefWorks Download